Bioresorbable implants are widely used in a variety of surgical procedures. The most common types of bioresorbable implants are bone-anchored, avascular, and cardiac. While they aren't perfect for every indication, they have become increasingly popular. The most common bioresorbable implant types are titanium, polyethylene, and saline-filled devices. They are also made from biodegradable polymers and can be used in a variety of surgical procedures.
Among the most popular uses of such implants are for cardiovascular procedures. The increasing prevalence of the cardiovascular disease is projected to increase the market for such implants. In fact, in 2016, 17.9 million people died worldwide due to cardiovascular disease. This is 31% of all deaths worldwide. In the coming years, the market for such implants is expected to grow at a 7.1% CAGR. According to the World Health Organization (WHO), the prevalence of cardiovascular diseases will propel the growth of this market. In fact, one in three deaths is caused by such diseases. In the U.S., approximately 300,000 people aged 65 years and older are hospitalized every year for broken hips. The majority of these injuries are the result of a fall. The bioresorbable implant market is segmented by application. The polymer segment includes polyglycolic acid, poly L-lactide, and polylactic acid. These three segments collectively account for more than 80% of the total market. This segment has numerous advantages over other implant types. These implants allow patients to enjoy the benefits of a medical device, as they are safe, reusable, and biodegradable.
These devices are designed to dissolve in the body and are replaced by natural bones. Moreover, bioresorbable implants are more cost-effective than conventional implants, allowing doctors to use them for a range of indications. The market is expected to grow at a significant pace, thanks to the increasing prevalence of chronic diseases and growing disposable income.
0 Comments